Package 72887-160-03

Brand: glycopyrrolate

Generic: glycopyrrolate
NDC Package

Package Facts

Identity

Package NDC 72887-160-03
Digits Only 7288716003
Product NDC 72887-160
Description

30 TABLET in 1 BOTTLE (72887-160-03)

Marketing

Marketing Status
Marketed Since 2021-11-29
Brand glycopyrrolate
Generic glycopyrrolate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5bc26249-4e9b-4870-a696-99779c90dc27", "openfda": {"unii": ["V92SO9WP2I"], "rxcui": ["1247658"], "spl_set_id": ["18ca98ed-522d-470f-bb22-908bbd7d489a"], "manufacturer_name": ["FH2 Pharma LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (72887-160-03)", "package_ndc": "72887-160-03", "marketing_start_date": "20211129"}], "brand_name": "GLYCOPYRROLATE", "product_id": "72887-160_5bc26249-4e9b-4870-a696-99779c90dc27", "dosage_form": "TABLET", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "72887-160", "generic_name": "GLYCOPYRROLATE", "labeler_name": "FH2 Pharma LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GLYCOPYRROLATE", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": "1.5 mg/1"}], "application_number": "ANDA091522", "marketing_category": "ANDA", "marketing_start_date": "20211129", "listing_expiration_date": "20261231"}